
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Fluorouracil
Therapeutic Area : Dermatology
Study Phase : Phase III
Sponsor : CBCC Global
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Fluorouracil is a Cytotoxic Drug drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Keratosis, Actinic.
Product Name : Undisclosed
Product Type : Cytotoxic Drug
Upfront Cash : Inapplicable
October 15, 2021
Lead Product(s) : Fluorouracil
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Sponsor : CBCC Global
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Diclofenac Sodium
Therapeutic Area : Dermatology
Study Phase : Phase III
Sponsor : Novum Pharmaceutical Research Services
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Diclofenac Sodium is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Keratosis, Actinic.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 01, 2019
Lead Product(s) : Diclofenac Sodium
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Sponsor : Novum Pharmaceutical Research Services
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Ketoconazole
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Novum Pharmaceutical Research Services | ACM Global Laboratories
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Ketoconazole is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Tinea Pedis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 31, 2019
Lead Product(s) : Ketoconazole
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Novum Pharmaceutical Research Services | ACM Global Laboratories
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Permethrin
Therapeutic Area : Dermatology
Study Phase : Phase III
Sponsor : Novum Pharmaceutical Research Services
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Permethrin is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Scabies.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
June 07, 2017
Lead Product(s) : Permethrin
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Sponsor : Novum Pharmaceutical Research Services
Deal Size : Inapplicable
Deal Type : Inapplicable
